Despite exponentially increased industry investment in oncology research and development with more than $80 billion spent annually, patient enrollment in clinical trials remains below 5% globally. Our multistakeholder international cancer coalition envisions ecosystem transformation with capacity building through a global "hub-and-spoke" network model to expand access to and accelerate clinical trials, thus ending cancer as a major cause of death in this lifetime.

中文翻译：

---

促进肿瘤学临床试验访问的全球健康公平性。


尽管行业对肿瘤学研发的投资呈指数级增长，每年花费超过 800 亿美元，但全球临床试验的患者入组率仍低于 5%。我们的多方利益相关者国际癌症联盟设想通过全球“中心辐射”网络模式进行能力建设，实现生态系统转型，以扩大临床试验的可及性并加速临床试验，从而终结癌症作为今生死亡的主要原因。